|Bid||0.00 x 800|
|Ask||0.00 x 900|
|Day's range||125.68 - 127.12|
|52-week range||87.68 - 132.30|
|Beta (5Y monthly)||0.80|
|PE ratio (TTM)||47.64|
|Earnings date||24 Aug 2021|
|Forward dividend & yield||2.52 (2.04%)|
|Ex-dividend date||24 June 2021|
|1y target est||139.85|
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the first patient procedure with the Hugo™ robotic-assisted surgery (RAS) system. The robotic prostatectomy was performed June 19 by urological surgeon Ruben Olivares, M.D., at Clínica Santa Maria in Santiago, Chile.
Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced it received U.S. Food and Drug Administration (FDA) expanded approval for the Arctic Front™ Family of Cardiac Cryoablation Catheters for the treatment of recurrent symptomatic paroxysmal atrial fibrillation (episodes that last less than seven continuous days) as an alternative to antiarrhythmic drug (AAD) therapy as an initial rhythm control strategy. The expanded indication is based on results from STOP AF First
Medtronic plc ( NYSE:MDT ) is about to trade ex-dividend in the next 4 days. The ex-dividend date is usually set to be...